Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Cholangiocarcinoma
Comparison of the Clinical Features, Treatment Patterns, and Tumor Mutations of Patients with Intrahepatic and Extrahepatic CCA
Read More
Cholangiocarcinoma
Institutional Review Data Indicate That Actionable Genetic Testing and Personalized Medicine in Hepatobiliary and Pancreatic Cancers Is Rarely Applied
Read More
Cholangiocarcinoma
Patient-Derived Organoids for Personalized Drug Screening in Intrahepatic CCA
Read More
Cholangiocarcinoma
Drug Sensitivities Are Predicted with Tumor Organoid-Based Functional Analysis in Patients with Cholangiocarcinoma
Read More
Cholangiocarcinoma
Importance of PKN2 Signaling in the Development of Drug Resistance in Patients with CCA and FGFR2 Fusion
Read More
Cholangiocarcinoma
Correlation of Next-Generation Sequencing and PCR Analysis of ctDNA with Clinical Outcomes and Emerging Mutations Linked to Drug Resistance
Read More
Cholangiocarcinoma
Benefits of Lenvatinib plus Pembrolizumab in Solid Tumors, Including Biliary Tract Cancer
Read More
Cholangiocarcinoma
Reduction of Tumor Burden, Promotion of Hepatic Progenitor-Cell Differentiation, and Induction of Antitumor Immunity in Intrahepatic CCA with Ivosidenib, a Selective IDH1 Inhibitor
Read More
Cholangiocarcinoma
Neoadjuvant Chemoradiation and Orthotopic Liver Transplantation versus Definitive Chemoradiation in Unresectable CCA
Read More
Cholangiocarcinoma
NTRK Gene Fusions in Biliary Tract Cancers
Read More
1
2
3
4
Page 3 of 4
Results 21 - 30 of 34